JMP Securities (NYSE:JMP) downgraded its rating on Savient Pharma (NASDAQ:SVNT) from market perform to market underperform and changed its price target to $1.50. The analyst issuing the downgrade believes that sales of its blockbuster drug Krystexxa will fall after competing drugs reach the market in a few years.
Shares are lower by about 6.4 percent.
Cisco Systems ( CSCO) was upgraded by Deutsche Bank (NYSE:DB) from a hold to buy with a $22.00 price target on the stock. Earnings, revenue and profit margins all beat forecasts.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.